Aarhus University logo

    • About
      • About the Nordic EMBL Partnership
      • Mission statement
      • EMBL non-tenure model
      • Contact
    • News
    • Collaborations
      • NORPOD - Postdoctoral Researcher Programme
      • NordForsk: Nordic EMBL Partnership Hub
      • How the Nordic EMBL Partnership is helping to fight COVID-19
      • Tools of the Trade Data Science Webinar Series
      • Nordic EMBL Partnership Meetings
      • Nordic EMBL Partnership Science and Art
    • Research
    • Technologies
    • Training
    • Careers
    • Internal

    Read more

    Click here to read more

    DANDRITE

    The Danish Research Institute of Translational Neuroscience (DANDRITE) is the Danish node of the Nordic EMBL Partnership, and performs basic and translational research in brain and the nervous system.

    FIMM

    The Institute for Molecular Medicine Finland (FIMM) is the Finnish node of the Nordic EMBL Partnership. FIMM’s research interests are human genomics and personalized medicine, with a focus on translational research.

    MIMS

    The Laboratory for Molecular Infection Medicine Sweden (MIMS) is the Swedish node of the Nordic EMBL Partnership. MIMS aims to strengthen Swedish research and enhance the dynamics in the field of molecular medicine.

    NCMBM

    The Norwegian Centre for Molecular Biosciences and Medicine (NCMBM) is the Norwegian node of the Nordic EMBL Partnership. NCMBM conducts molecular medicine & biotech research and works to translate these findings into clinical practice. 

    News from the Partnership


    Novel ge­n­omic tools in­crease the ac­cur­acy of breast cancer risk as­sess­ment

    15 December 2020 - Research news

    Findings from the FinnGen study encompassing 120,000 women indicate that inherited breast cancer risk should be assessed in an increasingly…

    AI pre­dicts which drug com­bin­a­tions kill cancer cells

    11 December 2020 - Research news

    A machine learning model developed in Finland, involving researchers at the Nordic EMBL Partnership's Finnish node, FIMM, can help us treat cancer…

    The COVID-19 Host Genetics Initiative: collaborating to understand how our genes affect our response to the coronavirus

    02 December 2020 - Research news

    Since the initial outbreak of the novel coronavirus SARS-Cov-2, researchers from many different disciplines have come together to try to decipher the…

    Ge­netic study shows that the risk of pre-eclamp­sia is re­lated to blood pres­sure and body mass in­dex

    26 November 2020 - Research news

    A large international study involving researchers from FIMM/Helsinki University has revealed that the genetic risk of pre-eclampsia – a potentially…

    Page 54 of 70.

    • Previous
    • 1
    • …
    • 53
    • 54
    • 55
    • …
    • 70
    • Next

    Upcoming Partnership Events


    No events found.

    Follow us!

    Follow us for the latest updates and insights! Join our community and stay connected with us on the following platforms

    LinkedIn
    Bluesky
    X

     

    About 

    News 

    Collaborations

    Research

    Technologies

    Training

    Careers

     

     

     

    Follow us

    X: @NordicEMBL

    LinkedIn: linkedin.com/company/nordic-embl-partnership-for-molecular-medicine

     

    The Nordic EMBL Partnership for Molecular Medicine combines the complementary research expertise of the Nordic countries with a common aim to address some of the biggest challenges in biomedicine today.

     

    Revised 21.03.2025

    © — Cookies at au.dk
    Privacy Policy
    Accessibility Statement

    15450 / i43